Home
Drug Development
Emerald Health and Lonza Enter Large-Scale Manufacturing Pact

Shimmer Launches Verisense Wearable Sensor Platform for Clinical Trials

Knight Therapeutics invests up to $125m in Latin America-focused Moksha8

Boehringer Ingelheim and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials

AbbVie and Teneobio Announce a Strategic Transaction to Develop a New Treatment for Multiple Myeloma

U.S. FDA Approves DARZALEX Split-Dosing Regimen

EC Approves ADCETRIS with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma

EC Approves Bristol-Myers Squibb’s Sprycel in Combination with Chemotherapy for Treatment of Pediatric Patients

Samsung Bioepis and C-Bridge Capital to Develop and Commercialize Next-Generation Biosimilars in China
Manufacturing
Supply Chain
Facilities
Health & Nutrition
Events
Contact Us

No Result

View All Result

No Result

View All Result

No Result

View All Result

bioLIVE China 2019 to be Newly Upgraded, to Lead the Development of the Bio-Pharma Technology in Asia

bioLIVE China 2019 to be Newly Upgraded, to Lead the Development of the Bio-Pharma Technology in Asia

by Content Team 11th January 2019

Exact Sciences and Pfizer Enter into U.S. Promotion Agreement for Cologuard®

by Content Team 29th August 2018

Drug Development

Daiichi Sankyo Launches NaruveinⓇ Injection for Cancer Pain Treatment in Japan

by Content Team 24th May 2018

Clinical Trials

Teva Announces Publication of Phase III Trial Data of Fremanezumab for the Preventive Treatment of Episodic Migraine in the Journal of the American Medical Association

by Content Team 21st May 2018

Chemspec Europe 2018:Introduction of Partnering Programme adds new level of networking

by Content Team 22nd March 2018

Lilly, Livongo team up for real-world diabetes research, aiming for better results in an outcomes-oriented market

by Content Team 13th February 2018

Clinical Trials

Chinese researchers report first lung stem cell transplantation clinical trial

by Content Team 13th February 2018

Drug Development

Using injectable self-assembled nanomaterials for sustained delivery of drugs Drug

by Content Team 13th February 2018

bioLIVE China 2019 to be Newly Upgraded, to Lead the Development of the Bio-Pharma Technology in Asia

Latest News

Emerald Health and Lonza Enter Large-Scale Manufacturing Pact

Drug Development

Emerald Health and Lonza Enter Large-Scale Manufacturing Pact

by Content Team

22nd February 2019

Emerald Health Pharmaceuticals and Lonza have entered an agreement for the large-scale manufacturing of a new synthetic derivative of cannabidiol ...

Clinical Trials

Shimmer Launches Verisense Wearable Sensor Platform for Clinical Trials

22nd February 2019

Drug Development

Knight Therapeutics invests up to $125m in Latin America-focused Moksha8

21st February 2019

Clinical Trials

Boehringer Ingelheim and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials

13th February 2019

Drug Development

AbbVie and Teneobio Announce a Strategic Transaction to Develop a New Treatment for Multiple Myeloma

13th February 2019

U.S. FDA Approves DARZALEX Split-Dosing Regimen

U.S. FDA Approves DARZALEX Split-Dosing Regimen

13th February 2019

EC Approves ADCETRIS with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma

EC Approves ADCETRIS with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma

12th February 2019

EC Approves Bristol-Myers Squibb’s Sprycel in Combination with Chemotherapy for Treatment of Pediatric Patients

EC Approves Bristol-Myers Squibb’s Sprycel in Combination with Chemotherapy for Treatment of Pediatric Patients

12th February 2019

Markets & Financial Moves

Aldeyra Therapeutics Expands Retinal Disease Pipeline with Acquisition of Helio Vision

Drug Development

Aldeyra Therapeutics Expands Retinal Disease Pipeline with Acquisition of Helio Vision

by Content Team

30th January 2019

Aldeyra Therapeutics, Inc. , a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients...

Bristol-Myers Squibb to acquire Celgene in $74bn deal

Bristol-Myers Squibb to acquire Celgene in $74bn deal

4th January 2019

Arsanis and X4 Pharmaceuticals enter into a definitive merger agreement

Arsanis and X4 Pharmaceuticals enter into a definitive merger agreement

30th November 2018

Allergan to Acquire Bonti Adding New Neurotoxin Programs to Medical Aesthetics Pipeline

19th September 2018

Novo Nordisk acquires Ziylo Ltd to accelerate its development of glucose responsive insulins

17th August 2018

Herbalife Nutrition Announces the Adjusted Price Range of Its Dutch Auction Tender Offer for Common Shares Following Stock-Split

Baxter Reports First-Quarter 2018 Results and Increases Financial Outlook for Full-Year 2018

Alexion Reports First Quarter 2018 Results And Positive Topline Data From ALXN1210 Phase 3 PNH Switch Study

Partners Pharmacy completes Acquisition of Presbyterian Village North Pharmacy

22nd March 2018

White Papers

Most Read

Emerald Health and Lonza Enter Large-Scale Manufacturing Pact

Drug Development

Emerald Health and Lonza Enter Large-Scale Manufacturing Pact

22nd February 2019

NFC-Label by Schreiner MediPharm for Ypsomed’s SmartPilot Supports Smart Self-Medication

NFC-Label by Schreiner MediPharm for Ypsomed’s SmartPilot Supports Smart Self-Medication

22nd February 2019

Most Popular

Shimmer Launches Verisense Wearable Sensor Platform for Clinical Trials

Shimmer Launches Verisense Wearable Sensor Platform for Clinical Trials

22nd February 2019

Knight Therapeutics invests up to $125m in Latin America-focused Moksha8

Knight Therapeutics invests up to $125m in Latin America-focused Moksha8

21st February 2019

Press Statements

Packaging & Logistics

Emerald Health and Lonza Enter Large-Scale Manufacturing Pact

Drug Development

Emerald Health and Lonza Enter Large-Scale Manufacturing Pact

22nd February 2019

NFC-Label by Schreiner MediPharm for Ypsomed’s SmartPilot Supports Smart Self-Medication

NFC-Label by Schreiner MediPharm for Ypsomed’s SmartPilot Supports Smart Self-Medication

22nd February 2019

Shimmer Launches Verisense Wearable Sensor Platform for Clinical Trials

Clinical Trials

Shimmer Launches Verisense Wearable Sensor Platform for Clinical Trials

22nd February 2019

Knight Therapeutics invests up to $125m in Latin America-focused Moksha8

Drug Development

Knight Therapeutics invests up to $125m in Latin America-focused Moksha8

21st February 2019

Medicine’s just the beginning: eyeforpharma Barcelona 2019 is at record attendance this is going to be the greatest one yet

Medicine’s just the beginning: eyeforpharma Barcelona 2019 is at record attendance this is going to be the greatest one yet

20th February 2019

Boehringer Ingelheim and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials

Clinical Trials

Boehringer Ingelheim and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials

13th February 2019

WuXi Biologics and Amicus Sign Exclusive Manufacturing Partnership

WuXi Biologics and Amicus Sign Exclusive Manufacturing Partnership

13th February 2019

AbbVie and Teneobio Announce a Strategic Transaction to Develop a New Treatment for Multiple Myeloma

Drug Development

AbbVie and Teneobio Announce a Strategic Transaction to Develop a New Treatment for Multiple Myeloma

13th February 2019

U.S. FDA Approves DARZALEX Split-Dosing Regimen

U.S. FDA Approves DARZALEX Split-Dosing Regimen

13th February 2019

Video Channel

Currently Playing

SAS Drug Development for Small/Midsize Pharmaceutical & Biotech

SAS Drug Development for Small/Midsize Pharmaceutical & Biotech

packaging automation for pharma industry

Drug Development

Research & Development

Astellas and KM Biologics Expiration of Distribution Agreement for Human Vaccines, etc. and Blood Plasma Products

Press Statements

Astellas and KM Biologics Expiration of Distribution Agreement for Human Vaccines, etc. and Blood Plasma Products

by Content Team

24th January 2019

Press Statements

SIRIO Pharma opens multimillion gummy production plant at new high-tech nutraceutical facility in Ma’anshan, China

by Content Team

12th November 2018

RetiPharma Secures Funding to Develop Treatments of Degenerative Eye Disorders

Drug Development

RetiPharma Secures Funding to Develop Treatments of Degenerative Eye Disorders

by Content Team

13th October 2018

Clinical Trials

Shimmer Launches Verisense Wearable Sensor Platform for Clinical Trials

Shimmer Launches Verisense Wearable Sensor Platform for Clinical Trials

22nd February 2019

Boehringer Ingelheim and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials

Boehringer Ingelheim and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials

13th February 2019

NeuroBo Pharmaceuticals to Initiate Phase III Clinical Trial of NB-01 in Adult Patients with Diabetic Neuropathic Pain

NeuroBo Pharmaceuticals to Initiate Phase III Clinical Trial of NB-01 in Adult Patients with Diabetic Neuropathic Pain

22nd January 2019

Bluebird bio and Celgene Corporation Present Initial Data from Phase 1 Clinical Study of Next-Generation Anti-BCMA CAR T Cell Therapy

Bluebird bio and Celgene Corporation Present Initial Data from Phase 1 Clinical Study of Next-Generation Anti-BCMA CAR T Cell Therapy

6th December 2018

QPS Expands U.S.-Based Phase I Clinical Trial Capabilities to Support the Growing Needs of Its Pharmaceutical, Biotechnology and CRO Partners

QPS Expands U.S.-Based Phase I Clinical Trial Capabilities to Support the Growing Needs of Its Pharmaceutical, Biotechnology and CRO Partners

5th December 2018

AMAL Therapeutics raises CHF 33.2 Million Series B Round

AMAL Therapeutics raises CHF 33.2 Million Series B Round

30th November 2018

Regulatory Approvals

U.S. FDA Approves DARZALEX Split-Dosing Regimen

U.S. FDA Approves DARZALEX Split-Dosing Regimen

13th February 2019

EC Approves ADCETRIS with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma

EC Approves ADCETRIS with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma

12th February 2019

EC Approves Bristol-Myers Squibb’s Sprycel in Combination with Chemotherapy for Treatment of Pediatric Patients

EC Approves Bristol-Myers Squibb’s Sprycel in Combination with Chemotherapy for Treatment of Pediatric Patients

12th February 2019

US FDA grants Breakthrough Therapy Designation for potential next-generation RSV medicine MEDI8897

8th February 2019

Neovasc Receives Approval to Proceed with Phase 2 of TIARA-II Study from Clinical Regulators in Germany and the UK

30th January 2019

CStone receives CTA approval in China to start Phase I trial for FGFR4 inhibitor BLU-554 (CS3008)

30th January 2019

Amgen Receives NMPA Approval For Repatha In China To Reduce The Risk Of Cardiovascular Events

29th January 2019

Sanofi secures FDA approval for flu vaccine in children

29th January 2019

Chinas National Medical Products Administration Approves Harvoni for Treatment of Chronic Hepatitis C Virus Genotype

7th January 2019

Facilities

Sharp enhances clinical IRT solution with latest investment

Sharp enhances clinical IRT solution with latest investment

7th February 2019

SGS expands testing capabilities at Glasgow facility

SGS expands testing capabilities at Glasgow facility

30th January 2019

Almac Group Extends Personalized Cancer Vaccine Production Facilities

Almac Group Extends Personalized Cancer Vaccine Production Facilities

22nd January 2019

Grifols Expands its Blood Typing Solutions Portfolio in the United States with Antisera Reagents

Manufacturing

Emerald Health and Lonza Enter Large-Scale Manufacturing Pact

Emerald Health and Lonza Enter Large-Scale Manufacturing Pact

22nd February 2019

NFC-Label by Schreiner MediPharm for Ypsomed’s SmartPilot Supports Smart Self-Medication

NFC-Label by Schreiner MediPharm for Ypsomed’s SmartPilot Supports Smart Self-Medication

22nd February 2019

Shimmer Launches Verisense Wearable Sensor Platform for Clinical Trials

Shimmer Launches Verisense Wearable Sensor Platform for Clinical Trials

22nd February 2019

Knight Therapeutics invests up to $125m in Latin America-focused Moksha8

Knight Therapeutics invests up to $125m in Latin America-focused Moksha8

21st February 2019

Events and Exhibitions

Health & Nutrition

GE Healthcare to open biotechnology manufacturing center in UK

Health & Nutrition

GE Healthcare to open biotechnology manufacturing center in UK

by Content Team

3rd December 2018

GE Healthcare announced the opening of a biotechnology manufacturing center at the Stevenage Bioscience Catalyst (SBC) Open Innovation Campus, in...

Nestle China accelerates innovation

Nestle China accelerates innovation

13th November 2018

GE increases cell culture media production capacity by tenfold

DSM invests to increase global Dyneema® production capacity

Natural History of Diabetes

9th February 2018

More News

EC Approves Bristol-Myers Squibb’s Sprycel in Combination with Chemotherapy for Treatment of Pediatric Patients

by Content Team

12th February 2019

EC Approves Bristol-Myers Squibb’s Sprycel in Combination with Chemotherapy for Treatment of Pediatric Patients

Bristol-Myers Squibb Co. announced that the EC has approved Sprycel in combination with chemotherapy for the treatment of pediatric patients...

Ompi and SiO2 Medical Products sign collaboration agreement

by Content Team

12th February 2019

Ompi and SiO2 Medical Products sign collaboration agreement

Ompi, the Italian glass primary packaging specialist for the pharmaceutical industry, has signed a collaboration agreement with SiO2 Medical Products...

Samsung Bioepis and C-Bridge Capital to Develop and Commercialize Next-Generation Biosimilars in China

by Content Team

12th February 2019

Samsung Bioepis and C-Bridge Capital to Develop and Commercialize Next-Generation Biosimilars in China

Samsung Bioepis Co., Ltd. announced its expansion in mainland China through a licensing agreement with C-Bridge Capital. The agreement covers...

US FDA grants Breakthrough Therapy Designation for potential next-generation RSV medicine MEDI8897

by Content Team

8th February 2019

US FDA grants Breakthrough Therapy Designation for potential next-generation RSV medicine MEDI8897

AstraZeneca and its global biologics research and development arm, MedImmune, announced that the US FDA has granted Breakthrough Therapy Designation...

Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development

by Content Team

8th February 2019

Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development

Solentim, a global leader in cell line development instrumentation, and bioengineering company ATUM announced a technology partnering and collaboration agreement....

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

Resources

System

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result

View All Result

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.